Abt Associates: Bold thinkers driving real-world impact
Tuberculosis is an ancient and curable disease of poverty that that continues to have a sturdy foothold among vulnerable populations during the past two decades, particularly in Africa and Asia. An estimated 8.7 million new tuberculosis (TB) cases and more than 1.4 million TB deaths were recorded worldwide in 2011, according to the 2012 World Health Organization Stop TB Partnership Global TB Report.
In 2013, World TB Day, held annually on March 24, is part of a two-year World Health Organization Stop TB Partnership Campaign to “End TB in Our Lifetime” by raising awareness and increasing commitments to fighting the disease on multiple fronts. Developing innovative models to effectively increase private sector participation in order to engage all care providers in high-quality TB care is one of the six components of the STOP TB strategy and is a significant part of Abt Associates’ USAID-funded TB reduction efforts. Other priorities include primary care health system strengthening and greater access to directly observed treatment regimens.
Abt Associates has been actively engaged in fighting TB since the late 1990s, as a global surge in HIV prevalence led to an unexpected resurgence of the near-dormant disease. For example, the Abt-led, USAID-funded Health Systems 20/20 project partnered with the government of Nigeria in 2011 to use smartphones to report data on TB treatment and supervision. The program streamlined and improved the accuracy of reporting, reduced human error in data entry, and uncovered ways to improve care delivery. The Health Finance and Governance (HFG) project – the successor to Health Systems 20/20 – continues this work. Abt also leads HFG.
Abt Associates is a mission-driven, global leader in research, evaluation and program implementation in the fields of health, social and environmental policy, and international development. Known for its rigorous approach to solving complex challenges, Abt Associates is regularly ranked as one of the top 20 global research firms and one of the top 40 international development innovators. The company has multiple offices in the U.S. and program offices in more than 40 countries.